Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Gastroenterology. 2010 Apr 22;139(2):430–438. doi: 10.1053/j.gastro.2010.04.044

Table 4.

Crohn’s Disease Therapies During Each Interval

Baseline to 6 Months
n=72
6 to 12 Months
n=67
12 months to LTFU
n=52
Systemic Glucocorticoids 44 (61%) 21 (31%) 16 (31%)
Median (range) mg/kg/day 0.19 (0.02,0.86) 0.15 (0.05,0.36) 0.04 (0.003,0.19)
Methotrexate 4 (6%) 6 (9%) 11 (21%)
6-Mercaptopurine 28 (39%) 33 (49%) 31 (60%)
Azathioprine 4 (6%) 5 (7%) 3 (6%)
Infliximab 5 (7%) 9 (13%) 13 (25%)
Enteral feeds 4 (6%) 3 (4%) 8 (15%)

Medication use expressed as n (%)